News

Published on 1 May 2024 on Zacks via Yahoo Finance

Can the 4 Medical Device Stocks Hit Targets This Earnings Season?


Article preview image

The earnings season for the Medical sector (one of the 16 broad Zacks sectors within the Zacks Industry classification) is in full swing now with several MedTech players already releasing their quarterly results. The quarterly performances have been encouraging so far despite companies still navigating ongoing macroeconomic headwinds, primarily in the form of worldwide geopolitical issues and healthcare labor shortages.

The latest Earnings Preview indicates that 16.7% of the companies in the Medical sector, constituting nearly 32.6% of the sector’s market capitalization, reported earnings until Apr 24. Of these, 70% beat earnings and revenue estimates. Earnings improved 0.7% year over year on the back of 3.6% higher revenues.

NYSE.GKOS price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Here's Why You Should Add Glaukos Stock to Your Portfolio Now

Glaukos Corporation GKOS is well-poised for growth on the back of favorable clinical trial result...

Zacks · via Yahoo Finance 9 Jan 2025

Glaukos Reaches 52-Week High: What's Driving the Stock's Rally?

Shares of Glaukos Corporation GKOS scaled a new 52-week high of $155.76 on Jan. 6, before closing...

Zacks · via Yahoo Finance 7 Jan 2025

Glaukos Stock Down Despite NDA Submission of Epioxa to the FDA

Glaukos Corporation GKOS recently announced that it has submitted its New Drug Application (NDA) ...

Zacks · via Yahoo Finance 24 Dec 2024

Here's Why You Should Add Glaukos Stock to Your Portfolio Now

Glaukos Corporation GKOS is well-poised for growth on the back of favorable clinical trial result...

Zacks · via Yahoo Finance 11 Dec 2024

Glaukos Stock Soars 77.9% Year to Date: What's Behind the Rally?

GKOS stock gains from strong product demand, international expansion and pipeline progress, which...

Zacks · via Yahoo Finance 21 Nov 2024

Eye Disease-Focused Glaukos' 'Investor Interest Should Continue To Gain Momentum:' Analyst - Glaukos...

Thursday, Glaukos Corporation GKOS reported a first-quarter adjusted EPS loss of $(0.70), up from...

Benzinga 3 May 2024

Glaukos (GKOS) Q1 Earnings Miss Estimates, Revenues Up Y/Y

Glaukos Corporation GKOS reported first-quarter 2024 adjusted loss of 70 cents per share, which i...

Zacks via Yahoo Finance 3 May 2024

Glaukos stock price target raised on strong Q1 sales By Investing.com

On Thursday, Glaukos Corporation (NYSE:GKOS) received an updated stock price target from Needham,...

Investing.com 3 May 2024

Can the 4 Medical Device Stocks Hit Targets This Earnings Season?

The earnings season for the Medical sector (one of the 16 broad Zacks sectors within the Zacks In...

Zacks via Yahoo Finance 1 May 2024

Here's Why You Should Retain Glaukos (GKOS) Stock for Now

Glaukos Corporation GKOS is well-poised for growth on the back of favorable clinical trial result...

Zacks via Yahoo Finance 15 Apr 2024